[Interstitial lung disease induced by raltitrexed-oxaliplatin based chemotherapy for colorectal cancer: a case report]

Farm Hosp. 2015 Mar 1;39(2):118-9. doi: 10.7399/fh.2015.39.2.8109.

[Article in Spanish]

Authors

Montserrat Carreres-Prieto¹, David López-Sisamón², Laura Layos-Romero³

Affiliations

¹ Servicio de Farmacia. Hospital Universitari de Bellvitge. Hospitalet de LLobregat, Barcelona.. montsecarrere@gmail.com.
² Unidad Farmacia Oncológica. Instititut Català Oncologia. Hospital Germans Trias i Pujol. Badalona, Barcelona.. montsecarrere@gmail.com.
³ Servicio de Oncología Médica. Instititut Català Oncologia. Hospital Germans Trias i Pujol. Badalona, Barcelona. montsecarrere@gmail.com.

PMID: 25817092
DOI: 10.7399/fh.2015.39.2.8109

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Anti-Inflammatory Agents / therapeutic use
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Colorectal Neoplasms / complications*
Colorectal Neoplasms / drug therapy*
Humans
Lung Diseases, Interstitial / chemically induced*
Lung Diseases, Interstitial / drug therapy
Male
Organoplatinum Compounds / administration & dosage
Oxaliplatin
Prednisone / therapeutic use
Quinazolines / administration & dosage
Thiophenes / administration & dosage

Substances

Anti-Inflammatory Agents
Organoplatinum Compounds
Quinazolines
Thiophenes
Oxaliplatin
raltitrexed
Prednisone